A real-world study to assess long-term therapy of testosterone undecanoate injections over 11 years in obese men with hypogonadism from a registry study
Latest Information Update: 21 Jun 2021
At a glance
- Drugs Testosterone undecanoate (Primary)
- Indications Hypogonadism
- Focus Adverse reactions
- 13 May 2021 Results assessing whether men with hypogonadism and excessive obesity benefit from long-term testosterone therapy presented at the 28th annual European Congress on Obesity
- 13 May 2021 Results of 12-years real-world data presented at the 28th annual European Congress on Obesity.
- 05 Oct 2020 New trial record